PRODUCT SEARCH
Advanced Search
SHOP BY CATEGORY
SHOP BY STYLE

SecurityMetrics for PCI Compliance, QSA, IDS, Penetration Testing, Forensics, and Vulnerability Assessment

Tuesday, 16 March 2010

Diabetic bracelet wearers told that some diabetic drugs are 'ineffective'

Research in the New England Journal of Medicine has found that two Novartis-made drugs have little or no effect on diabetes.

US and UK researchers looked at whether using a drug that lowers blood pressure or one that lowers blood sugar could stop high-risk patients developing diabetes.

However, the drugs Starlix (nateglinide) and Diovan (valsartan) have been found either to produce no decease in the number of diabetes sufferers or failed to alleviate the health problems triggered by diabetes.

Exercise and a healthy diet is the only way to keep healthy for those at risk from diabetes, researchers said as the results show the drugs are unlikely to decrease the number of people who wear a diabetic bracelet.

Co-author of the report, Professor John McMurray from the University of Glasgow, said: 'Losing as little as fiver per cent of body weight has been shown to make a dramatic difference [in preventing diabetes].'

In the UK seven million people are at risk of developing heart disease, Diabetic UK has said.
ADNFCR-2908-ID-19671553-ADNFCR

0 comments:

Post a Comment